An enterococcal phage protein inhibits type IV restriction enzymes involved in antiphage defense
Abstract The prevalence of multidrug resistant (MDR) bacterial infections continues to rise as the development of antibiotics needed to combat these infections remains stagnant. MDR enterococci are a major contributor to this crisis. A potential therapeutic approach for combating MDR enterococci is...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-08-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-51346-1 |